Literature DB >> 12801259

Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?

S Tangjitgamol1, S Manusirivithaya, C Sheanakul, S Leelahakorn, M Sripramote, T Thawaramara, N Kaewpila.   

Abstract

This study endeavored to determine whether lymph node size is a reliable indicator in determining lymph node metastasis in common epithelial ovarian cancer. We reviewed pathologic sections of pelvic and para-aortic lymph nodes removed from 104 ovarian carcinoma patients who underwent either primary surgical staging or secondary surgery from January 1994 to July 2001. All sections of each individual node were measured in two dimensions. The different sizes of nodes were studied statistically to determine the optimal sensitivity and specificity in predicting cancer metastasis. A nodal size of 10 mm was a specific point of interest. Of 2069 total nodes obtained, 110 nodes (5.3%) had metastatic cancer. More than half (55.4%) of these positive nodes had a nodal long axis of 10 mm and less. The sensitivity and specificity of nodal size at 10 mm were 44.5% and 81.1%, respectively. We conclude that lymph node size is not a good indicator in determining epithelial ovarian cancer metastasis. Mere sampling of only the enlarged nodes does not reflect the true positive incidence of nodal metastasis. To avoid inaccurate staging and improper management, complete lymph node dissection is proposed as part of surgical staging for ovarian cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12801259     DOI: 10.1046/j.1525-1438.2003.13192.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.

Authors:  Ximing Zhang; Min Li; Zhuopeng Tang; Xinyi Li; Ting Song
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

2.  Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding.

Authors:  S Fanti; C Nanni; P Castellucci; M Farsad; L Rampin; M D Gross; G Mariani; D Rubello
Journal:  Cancer Imaging       Date:  2006-03-23       Impact factor: 3.909

3.  The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.

Authors:  J K Chan; R Urban; J M Hu; J Y Shin; A Husain; N N Teng; J S Berek; K Osann; D S Kapp
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

4.  Gynecologic tumors: how to communicate imaging results to the surgeon.

Authors:  Stefania Rizzo; Giuseppina Calareso; Federica De Maria; Vanna Zanagnolo; Roberta Lazzari; Agnese Cecconi; Massimo Bellomi
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.